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INTRODUCTION 
Staphylococcus aureus is an important pathogen associated with food poisoning and one of the most prevalent agents of mastitis in cattle. In dairy products, the presence of S. aureus 
is usually associated with contamination of raw milk from animals with subclinical mastitis, or with post-pasteurization contamination due to improper handling of the product. Heat 
treatment of milk does not ensure the absence of the enterotoxins produced by numerous staphylococcal strains since they are heat stable. Bacteriophages and phage-encoded lytic 
proteins [endolysins and virion-associated peptidoglycan hydrolases (VAPGHs)] are a promising approach in the biocontrol of pathogens since they act as bactericidal agents degrading 
bacterial peptidoglycan. VAPGHs have a potential as antimicrobial agents due to their ability to lyse Gram positive bacteria on contact. In this work, our aim was to enhance the 
antimicrobial activity of the VAPGH HydH5, encoded by the S. aureus bacteriophage vB_SauS-phiIPLA88, against S. aureus by domain swapping using the bacteriocin lysostaphin. 
Possible synergistic effects between HydH5 and the endolysin LysH5, encoded by the same phage, were also tested to explore alternative enzybiotic-based strategies to fight against 
S. aureus infections.  
RESULTS  
Two single domains, CHAP and LYZ2, and four deletion constructs were generated from HydH5 (Fig.1). 
We also proceeded to determine whether the addition of the lysostaphin binding domain SH3b might 
increase the lytic activity of the full-length HydH5 and the CHAP domain. The lysostaphin binding 
domain SH3b was fused to the full-length HydH5 protein, resulting in a protein with two catalytic 
domains and one cell wall binding (CWB) domain (HydH5SH3b). A second construct was obtained by 
fusion of the CHAP156 domain to the lysostaphin SH3b domain (CHAPSH3b). Finally, the full-length 
lysostaphin and HydH5 were fused in order to obtain a protein with three catalytic domains and a 
CWB domain (HydH5Lyso).  
Fusion to lysostaphin sequences increases HydH5 and CHAP lytic activities 
Figure 1. Schematic representation of HydH5 deletion and fusion constructs. The numbers indicate the initial and final amino acids 
in the domains as determined by Pfam domain database. Red box: CHAP domain; Blue box: LYZ2 domain; Green box: SH3b domain; 
large black box: endopeptidase domain; small black box: 6×His-tag 
CONCLUSIONS 
The novel chimeric proteins generated by combination between HydH5 and lysostaphin have improved  lytic activity against S. aureus, including MRSA N315 and S. epidermidis. On the other hand, 
the effectiveness of HydH5 and its derivative fusions when used in combination with LysH5, another dairy derived anti-staphylococcal protein, were remarkable. We expect that these constructs 
will provide new weapons to combat multidrug-resistant S. aureus infections in both dairy and clinical environments.  
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In the turbidity reduction assay (Fig. 2C), the fusion proteins HydH5Lyso and 
HydH5SH3b (1 µM), showed a 2.5- and 1.7-fold higher specific activity than the 
parental protein HydH5, respectively. HydH5Lyso had 1.5-fold higher activity 
than HydH5SH3b. CHAPSH3b, with an activity 4.8-fold greater than CHAP 
domain, showed the highest lytic activity obtained from HydH5 fusions. 
 
Figure 2. Antimicrobial activity of HydH5, deletion and fusion constructs. A) SDS-PAGE and zymogram 
analysis of 5 µg nickel affinity purified proteins. Lane M: Standard molecular mass marker (BioRad); lane 
1, CHAP (19.6 kDa); 2, HydH5 (73.6 kDa); 3, HydH5SH3b (85.1 kDa); 4, HydH5Lyso (100.8 kDa); 5, 
CHAPSH3b (30.4 kDa); 6, Lysostaphin (28.1 kDa).  B) Plate lysis assay of HydH5 and derived proteins 
using mid-log phase growing cells of S. aureus Sa9 and MRSA strain N315. C) Turbidity reduction assay 
results using 1 µM of each protein. Specific activity is expressed as ΔOD600nm min-1µM-1. Error bars are 
the means ± standard deviations of three independent assays. 
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HydH5 and its derived fusion proteins act 
synergistically with endolysin LysH5 against S. aureus 
Figure 3. Representative graphs of the synergistic interaction between LysH5 and HydH5 and between 
LysH5 and each HydH5-lysostaphin construct 
The lytic activity of HydH5 and its derivative fusions is specific 
for staphylococci 
All proteins were active against S. aureus and Staphylococcus epidermidis strains but no other 
genus was lysed at detectable levels (data not shown). In general, S. aureus strains were more 
sensitive to lysis than S. epidermidis strains. Within the S. aureus strains, bovine strains were 
more sensitive than clinical strains. This could be due to the fact that bovine strains and the 
phage from which HydH5 originated have been isolated from the dairy environment. 
As shown in Fig. 2A, all proteins created a single zone of clearing in the zymogram assay, consistent with the predicted molecular mass and positions of the nickel affinity purified  
proteins in the SDS-PAGE. In the plate lysis assay (Fig. 2B) all the fusion proteins showed significantly greater activity than the parental protein HydH5, even against the methicillin-
resistant (MRSA) S. aureus N315 strain. Of note, fusion of SH3b to the CHAP domain increased CHAP activity 64-fold (Fig. 2B).  
HydH5 deletions and fusion proteins 
 
 
A sinergistic effect was observed when HydH5 and its derived fusions were 
combined with LysH5. Lower proteins concentration was needed to fully 
decrease the S. aureus Sa9 OD600nm . 
